Lost Circulation Compositions Comprising Pumice and Associated Methods

US2017036959A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2017036959-A1
Application numberUS-201615332491-A
CountryUS
Kind codeA1
Filing dateOct 24, 2016
Priority dateMar 9, 2012
Publication dateFeb 9, 2017
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed are lost circulation treatment fluids and methods of sealing lost circulation zones. Embodiments include a lost circulation treatment fluid comprising pumice, hydrated lime, a set retarder, and water.

First claim

Opening claim text (preview).

What is claimed is: 1 . A lost circulation treatment fluid comprising: pumice, hydrated lime, a set retarder, and water. 2 . The lost circulation treatment fluid of claim 1 wherein the lost circulation treatment fluid has a shear-thinning index of less than 1 as calculated by the Herschel-Bulkley model. 3 . The lost circulation treatment fluid of claim 1 wherein the lost circulation treatment fluid further comprises aluminum sulfate. 4 . The lost circulation treatment fluid of claim 1 wherein the set retarder comprises at least one retarder selected from the group consisting of a phosphonic acid, a phosphonic acid derivative, a lignosulfonate, a salt, an organic acid, a carboxymethylated hydroxyethylated cellulose, a synthetic co- or ter-polymer comprising sulfonate and carboxylic acid groups, a borate compound, and any mixture thereof. 5 . The lost circulation treatment fluid of claim 1 wherein the lost circulation treatment fluid further comprises a dispersant selected from the group consisting of a sulfonated-formaldehyde-based dispersant, a polycarboxylated ether dispersant, and any combination thereof. 6 . The lost circulation treatment fluid of claim 1 wherein the set retarder comprises a phosphonic acid derivative, and wherein the set-delayed cement composition further comprises a polycarboxylated ether dispersant. 7 . The lost circulation treatment fluid of claim 1 wherein the lost circulation treatment fluid further comprises a cement set activator, and wherein the cement set activator comprises at least one cement set activator selected from the group consisting of calcium chloride, triethanolamine, sodium silicate, zinc formate, calcium acetate, sodium hydroxide, sodium sulfate, nanosilica, sodium hexametaphosphate, and any combinations thereof. 8 . The lost circulation treatment fluid of claim 1 wherein the lost circulation treatment fluid has a density in the range of from about 8 lb/gal to about 17 lb/gal. 9 . A lost circulation treatment fluid comprising: pumice, hydrated lime, a set retarder, and water; wherein the lost circulation treatment fluid has a shear-thinning index of less than 1 as calculated by the Herschel-Bulkley model, wherein the lost circulation treatment fluid has a static gel strength of at least about 100 lb/100 ft 2 at a temperature of about 50° F. to about 200° F. 10 . The lost circulation treatment fluid of claim 9 wherein the lost circulation treatment fluid has a shear-thinning index of less than 1 as calculated by the Herschel-Bulkley model. 11 . The lost circulation treatment fluid of claim 9 further comprising aluminum sulfate. 12 . The lost circulation treatment fluid of claim 9 wherein the set retarder comprises at least one retarder selected from the group consisting of a phosphonic acid, a phosphonic acid derivative, a lignosulfonate, a salt, an organic acid, a carboxymethylated hydroxyethylated cellulose, a synthetic co- or ter-polymer comprising sulfonate and carboxylic acid groups, a borate compound, and any mixture thereof. 13 . The lost circulation treatment fluid of claim 9 further comprising a dispersant selected from the group consisting of a sulfonated-formaldehyde-based dispersant, a polycarboxylated ether dispersant, and any combination thereof. 14 . The lost circulation treatment fluid of claim 9 wherein the set retarder comprises a phosphonic acid derivative, and wherein the set-delayed cement composition further comprises a polycarboxylated ether dispersant. 15 . The lost circulation treatment fluid of claim 9 further comprising a cement set activator, and wherein the cement set activator comprises at least one cement set activator selected from the group consisting of calcium chloride, triethanolamine, sodium silicate, zinc formate, calcium acetate, sodium hydroxide, sodium sulfate, nanosilica, sodium hexametaphosphate, and any combinations thereof. 16 . The lost circulation treatment fluid of claim 9 wherein the lost circulation treatment fluid is a set-delayed cement composition capable of remaining in a pumpable fluid state for about 1 day or longer at a temperature of about 100° F. 17 . The lost circulation treatment fluid of claim 9 wherein the lost circulation treatment fluid has a static gel strength of at least about 500 lb/100 ft 2 at a temperature of about 50° F. to about 200° F. 18 . A lost circulation treatment system comprising: a lost circulation treatment fluid comprising: pumice, hydrated lime, a set retarder, and water, wherein the lost circulation treatment fluid is a set-delayed cement composition capable of remaining in a pumpable fluid state for about 1 day or longer at a temperature of about 100° F.; and a cement set activator. 19 . The lost circulation treatment system of claim 18 wherein the lost circulation treatment fluid has a shear-thinning index of less than 1 as calculated by the Herschel-Bulkley model. 20 . The lost circulation treatment system of claim 18 wherein the lost circulation treatment fluid has a static gel strength of at least about 100 lb/100 ft 2 at a temperature of about 50° F. to about 200° F.

Assignees

Inventors

Classifications

  • containing additives for specific purposes · CPC title

  • containing mixtures of the silica-lime type · CPC title

  • Set retarders · CPC title

  • Methods or devices for cementing, for plugging holes, crevices or the like · CPC title

  • Retarder inhibited mortars activated by the addition of accelerators or retarder-neutralising agents · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2017036959A1 cover?
Disclosed are lost circulation treatment fluids and methods of sealing lost circulation zones. Embodiments include a lost circulation treatment fluid comprising pumice, hydrated lime, a set retarder, and water.
Who is the assignee on this patent?
Halliburton Energy Services Inc
What technology area does this patent fall under?
Primary CPC classification C09K8/487. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Feb 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).